Global Patent Index - EP 4168970 A1

EP 4168970 A1 20230426 - METHOD FOR DETERMINING INDIVIDUAL CARE-PRODUCT FORMULATIONS

Title (en)

METHOD FOR DETERMINING INDIVIDUAL CARE-PRODUCT FORMULATIONS

Title (de)

VERFAHREN ZUR BESTIMMUNG INDIVIDUELLER PFLEGEMITTELFORMULIERUNGEN

Title (fr)

PROCÉDÉ DE DÉTERMINATION DE FORMULATIONS DE PRODUITS DE SOINS PERSONNELS

Publication

EP 4168970 A1 20230426 (DE)

Application

EP 21739267 A 20210618

Priority

  • DE 102020116304 A 20200619
  • EP 2021066721 W 20210618

Abstract (en)

[origin: CA3183167A1] The invention relates to a method for the automated determination of an individual care product formulation for a user, comprising: - a feature input routine for establishing individual skin features of the user; - creating a user vector based on this data; - creating, based on the user vector and by means of a multilayer neural network, a feature vector containing the properties and functionalities of the care product formulation to be determined, - wherein the neural network is formed in a first formulation cycle for the user with a learning vector set consisting of parameterized expertise, - wherein the learning vector set is adapted in further formulation cycles through the capture of changes in individual skin features after the application of a previously determined care product formulation, - creating the individual care product formulation based on the feature vector and an ingredient constraint database using a loss-function optimization method; - a feature change routine for inputting changes in skin features of the user after the application of a care product according to the care product formulation in order to modify the learning vector set. The method according to the invention represents a hybrid approach which initially includes background knowledge of domain experts (i.e. dermatologists) who specify an initial mapping. This is augmented by a structured analysis of user feedback, which increases accuracy.

IPC 8 full level

G06Q 30/06 (2023.01); A61K 8/96 (2006.01); A61Q 19/00 (2006.01)

CPC (source: EP US)

A61K 8/18 (2013.01 - EP); A61Q 19/00 (2013.01 - EP); G06N 3/0409 (2013.01 - US); G06Q 30/0621 (2013.01 - EP); G06Q 30/0627 (2013.01 - EP); G16H 20/10 (2017.12 - US); A61B 5/441 (2013.01 - US)

Citation (search report)

See references of WO 2021255289A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

Designated validation state (EPC)

KH MA MD TN

DOCDB simple family (publication)

DE 102020116304 A1 20211223; CA 3183167 A1 20211223; CN 115885305 A 20230331; EP 4168970 A1 20230426; US 2023268046 A1 20230824; WO 2021255289 A1 20211223

DOCDB simple family (application)

DE 102020116304 A 20200619; CA 3183167 A 20210618; CN 202180043561 A 20210618; EP 2021066721 W 20210618; EP 21739267 A 20210618; US 202118011452 A 20210618